Consolidation Radiotherapy following Brief Chemotherapy for Localized Diffuse Large B-cell Lymphoma: A Prospective Study

2003 ◽  
Vol 44 (9) ◽  
pp. 1535-1539 ◽  
Author(s):  
Kouichi Isobe ◽  
Hiroyuki Kawakami ◽  
Jun-Ichi Tamaru ◽  
Shigeo Yasuda ◽  
Takashi Uno ◽  
...  
2003 ◽  
Vol 44 (9) ◽  
pp. 1535-1539 ◽  
Author(s):  
Kazuo Hatano ◽  
Toshiyuki Takagi ◽  
Atsuo Mikata ◽  
Hisao Ito ◽  
Tetsuya Kawata ◽  
...  

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e19508-e19508
Author(s):  
Prem Raj Shrestha ◽  
Tongyu Lin ◽  
He Huang ◽  
Huang Ming Hong ◽  
Xueying Li ◽  
...  

2019 ◽  
Vol 08 (01) ◽  
pp. 57-59 ◽  
Author(s):  
Babu Suresh ◽  
Vikas Asati ◽  
K. C. Lakshmaiah ◽  
Govind Babu ◽  
D. Lokanatha ◽  
...  

Abstract Background: Gastrointestinal tract (GIT) is the most common extranodal site for non-Hodgkin's lymphoma (NHL) and constitutes about 10%-15% of all NHL. This was a prospective study to evaluate the epidemiological, clinicopathological characteristics, and treatment outcome of primary GIT diffuse large B-cell lymphoma (PGIL). Materials and Methods: Newly diagnosed patients of PGIL with DLBCL histology were eligible. Lugano staging system was used. All patients were treated with prephase treatment (1 mg vincristine and 100 mg prednisolone) followed by CHOP-based chemotherapy (with or without rituximab) as definitive treatment. Results: A total of 21 patients of PGIL were diagnosed. The median age was 46 years (range: 27–69 years) with male:female ratio of 2:1. Dull aching abdominal pain was the most common presenting complaint. Stomach was the most common site involved (52.4%, n = 11) followed by the colon (23.8%, n = 5). The estimated median survival in patients with Stage IV disease was significantly lower as compared to patients with localized disease (Stage I and II) (6.23 months vs. 23.4 months; P = 0.04). Patients, who did not achieve complete response (CR), had 15.5 times higher risk of death, as compared to those who achieved CR (P = 0.01). Conclusions: Stomach was the most common site for PGIL. Localized disease and CR after first-line chemotherapy were associated with better survival. A higher cost of rituximab was the prohibitive factor for cure in these patients.


2003 ◽  
Vol 15 (2) ◽  
pp. 1-5 ◽  
Author(s):  
James K. Liu ◽  
Peter Kan ◽  
Meic H. Schmidt

Primary lymphomas of the sacrum are rare tumors, reported only in a few cases in the literature. The authors describe two patients with diffuse large B-cell lymphomas presenting as a sacral tumor. In the first case a 52-year-old man presented with progressive back pain, bilateral radicular pain, and saddle block anesthesia secondary to a lytic, expansile soft-tissue mass. The mass arose from the sacrum and eroded through the right S-1 to S-4 foramina and extended into the epidural space of the spinal canal. On magnetic resonance imaging, the sacral mass enhanced homogeneously with Gd. In the second case a 64-year-old man presented with left-sided radicular pain, paresthesias, and progressive weakness due to a lytic soft-tissue mass in the left sacral ala extending into the left L-5 and S-1 foramina. Metastatic workup in each patient demonstrated unremarkable findings. In both cases, an open biopsy procedure was performed after nondiagnostic examination of needle biopsy samples. Histopathological examination showed evidence consistent with diffuse large B-cell lymphoma in both patients. In the first case the disease was classified as Stage IAE, and the patient subsequently underwent four cycles of cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP)– and rituximab-based chemotherapy followed by consolidation radiotherapy. In the second case the disease was also classified as Stage IAE, and the patient underwent CHOP-based chemotherapy and consolidation radiotherapy. In both cases radiography demonstrated a decrease in size of the sacral lymphomas. The authors review the clinical, radiological, and histological features of sacral lymphomas. Lymphoma should be considered in the differential diagnosis of sacral tumors.


Haematologica ◽  
2020 ◽  
pp. haematol.2020.249680
Author(s):  
Martin D. Berger ◽  
Sven Trelle ◽  
Annina E. Büchi ◽  
Sabrina Jegerlehner ◽  
Codruta Ionescu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document